Oral Pancreatic Enzyme Substitution Therapy in Chronic Pancreatitis: Is Clinical Response an Appropriate Marker for Evaluation of Therapeutic Efficacy?

  • J Enrique Domínguez-Muñoz Department of Gastroenterology and Foundation for Research in Digestive Diseases (FIENAD), University Hospital of Santiago de Compostela. Santiago de Compostela, Spain
  • Julio Iglesias-García Department of Gastroenterology and Foundation for Research in Digestive Diseases (FIENAD), University Hospital of Santiago de Compostela. Santiago de Compostela, Spain
Keywords: Body Mass Index, Enzyme Replacement Therapy, Nutritional Status, Pancreatitis, Chronic, Prealbumin, Retinol-Binding Proteins, Transferrin


Context Malnutrition secondary to pancreatic exocrine insufficiency plays a prognostic role in chronic pancreatitis. Enzyme substitution therapy is generally prescribed to avoid diarrhea and weight loss, although it is unknown whether this is associated with normal absorption of nutrients and a normal nutritional status. Objective We aimed to evaluate whether an adequate clinical response to enzyme therapy can be used to predict a normal nutritional status in patients with chronic pancreatitis. Patients Thirty-one consecutive patients (25 males, 6 females; mean age 52 years,) with severe chronic pancreatitis and steatorrhea were enrolled in the study. Intervention Enzyme substitution therapy was indicated in cases with severe steatorrhea (more than 15 g/day), diarrhea and/or weight loss. Therapy was optimized in individual patients to obtain complete symptom relief. Main outcome measure A nutritional evaluation including body mass index and serum levels of retinol-binding protein, prealbumin and transferrin was carried out. Results Ten out of ten patients with asymptomatic steatorrhea, who did not fulfill the criteria for enzyme substitution therapy, and 11 out of 21 patients (52.4%) with symptomatic or more severe steatorrhea, who were under enzyme substitution therapy, showed a deficient nutritional status. Conclusions An appropriate clinical response to enzyme substitution therapy does not allow the prediction of a normal nutritional status in patients with chronic pancreatitis.

Image: Nutritional parameters in individual patients with severe chronic pancreatitis.


Download data is not yet available.


Layer P, Yamamoto H, Kalthoff L, Clain JE, Bakken LJ, DiMagno EP. The different courses of early- and late-onset idiopathic and alcoholic chronic pancreatitis. Gastroenterology 1994; 107:1481-7. [PMID 7926511] (FULL TEXT: http://download.journals.elsevierhealth.com/pdfs/journals/0016-5085/PII0016508594905533.pdf)

Montalto G, Soresi M, Carroccio A, Scafidi E, Barbagallo CM, Ippolito S, Notarbartolo A. Lipoproteins and chronic pancreatitis. Pancreas 1994; 9:137-8. [PMID 8108368] (FULL TEXT: http://journals.lww.com/pancreasjournal/Citation/1994/01000/Lipoproteins_and_Chronic_Pancreatitis.21.aspx)

Domínguez-Muñoz JE. Pancreatic enzyme therapy for pancreatic exocrine insufficiency. Curr Gastroenterol Rep 2007; 9:116-22. [PMID 17418056] (FULL TEXT: http://www.current-reports.com/article_frame.cfm?PubID=GR09-2-1-03&Type=Article)

Delchier JC, Vidon N, Saint-Marc Girardin MF, Soule JC, Moulin C, Huchet B, Zylberberg P. Fate of orally ingested enzymes in pancreatic insufficiency: comparison of two pancreatic enzyme preparations. Aliment Pharmacol Ther 1991; 5:365-78. [PMID 1777547] (FULL TEXT: http://www3.interscience.wiley.com/cgi-bin/fulltext/119353178/PDFSTART)

Meyer JH, Elashoff J, Porter-Fink V, Dressman J, Amidon GL. Human postprandial gastric emptying of 1-3-millimeter spheres. Gastroenterology 1988; 94:1315-25. [PMID 3360258] (FULL TEXT: http://download.journals.elsevierhealth.com/pdfs/journals/0016-5085/PII0016508588906695.pdf)

Domínguez-Muñoz JE, Birckelbach U, Glasbrenner B, Sauerbruch T, Malfertheiner P. Effect of oral pancreatic enzyme administration on digestive function in healthy subjects: comparison between two enzyme preparations. Aliment Pharmacol Ther 1997; 11:403-8. [PMID 9146782] (FULL TEXT: http://www3.interscience.wiley.com/cgi-bin/fulltext/119154234/PDFSTART)

Dutta SK, Hubbard VS, Appler M. Critical examination of therapeutic efficacy of a pH-sensitive enteric-coated pancreatic enzyme preparation in treatment of exocrine pancreatic insufficiency secondary to cystic fibrosis. Dig Dis Sci 1988; 33:1237-44. [PMID 3168696] (FULL TEXT: http://www.springerlink.com/content/l38tw18442223425/fulltext.pdf)

Lankisch PG, Lembcke B, Göke B, Creutzfeldt W. Therapy of pancreatogenic steatorrhoea: does acid protection of pancreatic enzymes offer any advantage? Z Gastroenterol 1986; 24:753-7. [PMID 3548109]

Domínguez-Muñoz JE, Iglesias-García J, Iglesias-Rey M, Figueiras A, Vilariño-Insua M. Effect of the administration schedule on the therapeutic efficacy of oral pancreatic enzyme supplements in patients with exocrine pancreatic insufficiency: a randomized, three-way crossover study. Aliment Pharmacol Ther 2005; 21:993-1000. [PMID 15813835] (FULL TEXT: http://www3.interscience.wiley.com/cgi-bin/fulltext/118696557/HTMLSTART)

Domínguez-Muñoz JE, Iglesias-García J, Iglesias-Rey M, Vilariño-Insua M. Optimising the therapy of exocrine pancreatic insufficiency by the association of a proton pump inhibitor to enteric coated pancreatic extracts. Gut 2006; 55:1056-7. [PMID 16766768] (FULL TEXT: http://gut.bmj.com/content/55/7/1056.2.long)

Villalba-Martin C, Domínguez-Muñoz JE. Role of imaging methods in diagnosing, staging, and detecting complications of chronic pancreatitis in clinical practice: should MRCP and MRI replace ERCP and CT? In: Dominquez-Munoz, E eds , Clinical pancreatology, 1st ed, Blackwell, Oxford, pp 236-45.

Wiersema MJ, Hawes RH, Lehman GA, Kochman ML, Sherman S, Kopecky KK. Prospective evaluation of endoscopic ultrasonography and endoscopic retrograde cholangiopancreatography in patients with chronic abdominal pain of suspected pancreatic origin. Endoscopy 1993; 25:555-64. [PMID 8119204]

Mason JB. Nutritional assessment and management of the malnourished patient. In: Sleisinger and Fordtran’s Gastrointestinal and Liver Disease, 8th ed. eds Feldman M, Friedman L, Brandt l Elsevier (Philadelphia), 2006, pp. 319-356.

Domínguez-Muñoz JE, Iglesias-García J, Vilariño-Insua M, Iglesias-Rey M. 13C-mixed triglyceride breath test to assess oral enzyme substitution therapy in patients with chronic pancreatitis. Clin Gastroenterol Hepatol 2007; 5:484-8. [PMID 17445754] (FULL TEXT: http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B7GGW-4NHD114-K&_user=839424&_coverDate=04%2F30%2F2007&_rdoc=1&_fmt=full&_orig=search&_cdi=20161&_sort=d&_docanchor=&view=c&_acct=C000045367&_version=1&_urlVersion=0&_userid=839424&md5=74cd1d16b34d1a6df11717f81cf11508)

Singh S, Midha S, Singh N, Joshi YK, Garg PK. Dietary counseling versus dietary supplements for malnutrition in chronic pancreatitis: a randomized controlled trial. Clin Gastroenterol Hepatol 2008; 6:353-9. [PMID 18328440] (FULL TEXT: http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B7GGW-4S07TCB-D&_user=839424&_coverDate=03%2F31%2F2008&_rdoc=1&_fmt=full&_orig=search&_cdi=20161&_sort=d&_docanchor=&view=c&_acct=C000045367&_version=1&_urlVersion=0&_userid=839424&md5=16c6cef76191e710031319eb08c8bc49)

Nutritional parameters in individual patients with severe chronic pancreatitis
How to Cite
Domínguez-MuñozJ., & Iglesias-GarcíaJ. (2010). Oral Pancreatic Enzyme Substitution Therapy in Chronic Pancreatitis: Is Clinical Response an Appropriate Marker for Evaluation of Therapeutic Efficacy?. JOP. Journal of the Pancreas, 11(2), 158-162. https://doi.org/10.6092/1590-8577/3852